Artificial Pancreas Device System Market Research Report by Type (CTR, CTT), End-user (Hospitals, Medical Centers, and Others), and Region (North America, Europe, APAC, RoW)- Forecast to 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Artifical Pancreas Device System (APDS) Market, by Type

6.1 Introduction

6.2 CTR (Control to Range) Systems

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

6.3 CTT (Control to Target) Systems

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

Chapter 7. Global Artifical Pancreas Device System (APDS) Market, by End User

7.1 Introduction

7.2 Hospitals

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

7.3 Medical Centers

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

7.4 Others

Chapter 8. Global Artifical Pancreas Device System (APDS) Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 U.K.

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 Republic of Korea

8.4.6 Rest of Asia Pacific

8.5 The Middle East & Africa

8.5.1 The Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Medtronic plc

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Bigfoot Biomedical

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Johnson & Johnson

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Dexacom, Inc.

10.4.1 Company Overview

10.4.2 Technologys/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 CELLNOVO

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Tandem Diabetes Care, Inc.

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Pancreum, Inc.

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 TypeZero Technologies, LLC

10.8.1 Overview

10.8.2 Product/ Technology Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Beta Bionics

10.9.1 Overview

10.9.2 Product Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 F. Hoffmann-La Roche Ltd

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 Inreda Diabetic B.V.

10.11.1 Overview

10.11.2 Product Overview

10.11.3 Financials

10.11.4 Key Developments

10.11.5 SWOT Analysis

10.12 Insulet Corp

10.12.1 Overview

10.12.2 Product Overview

10.12.3 Financials

10.12.4 Key Developments

10.12.5 SWOT Analysis

10.13 Others

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View Point

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Prediction of the Artifical Pancreas Device System (APDS) Industry

Chapter 12 Appendix

LIST OF TABLES

Table 1 Global Artifical Pancreas Device System (APDS) Market Synopsis, 2020-2027(USD Million)

Table 2 Global Artifical Pancreas Device System (APDS) Market Estimates and Forecast, 2018– 2023, (USD Million)

Table 3 Global Artifical Pancreas Device System (APDS) Market, by Region, 2020-2027, (USD Million)

Table 4 Global Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 5 Global Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 6 Global Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

Table 7 North America Global Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 8 North America Global Artifical Pancreas Device System (APDS) Market, by End User, 2020-2027, (USD Million)

Table 9 US Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 10 US Artifical Pancreas Device System (APDS) Market, by Technology, 2020-2027, (USD Million)

Table 11 US Artifical Pancreas Device System (APDS) Market, by End User, 2020-2027, (USD Million)

Table 12 Canada Artifical Pancreas Device System (APDS) Market,by Type, 2020-2027, (USD Million)

Table 13 Canada Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

Table 14 South America Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 15 South America Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

Table 16 Europe Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 17 Europe Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

Table 18 Western Europe Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 19 Western Europe Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

Table 20 Eastern Europe Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 21 Eastern Europe Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

Table 22 Asia Pacific Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 23 Asia Pacific Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

Table 24 Middle East & Africa Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

Table 25 Middle East & Africa Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Artifical Pancreas Device System (APDS) Market

Figure 3 Segmentation Market Dynamics for Global Artifical Pancreas Device System (APDS) Market

Figure 4 Global Artifical Pancreas Device System (APDS) Market Share, by Type 2020

Figure 5 Global Artifical Pancreas Device System (APDS) Market Share, by End-User, 2020

Figure 6 Global Artifical Pancreas Device System (APDS) Market Share, by Region, 2020

Figure 7 North America Artifical Pancreas Device System (APDS) Market Share, by Country, 2020

Figure 8 Europe Artifical Pancreas Device System (APDS) Market Share, by Country, 2020

Figure 9 Asia Pacific Artifical Pancreas Device System (APDS) Market Share, by Country, 2020

Figure 10 Middle East & Africa Artifical Pancreas Device System (APDS) Market Share, by Country, 2020

Figure 11 Global Artifical Pancreas Device System (APDS) Market: Company Share Analysis, 2020 (%)

Figure 12 Medtronic plc: Key Financials

Figure 13 Medtronic plc: Segmental Revenue

Figure 14 Medtronic plc: Geographical Revenue

Figure 15 Bigfoot Biomedical: Key Financials

Figure 16 Bigfoot Biomedical: Segmental Revenue

Figure 17 Bigfoot Biomedical: Geographical Revenue

Figure 18 Johnson & Johnson::Key Financials

Figure 19 Johnson & Johnson: Segmental Revenue

Figure 20 Johnson & Johnson: Geographical Revenue

Figure 21 Dexacom, Inc.: Key Financials

Figure 22 Dexacom, Inc.: Segmental Revenue

Figure 23 Dexacom, Inc.: Geographical Revenue

Figure 24 CELLNOVO:Key Financials

Figure 25 CELLNOVO: Segmental Revenue

Figure 26 CELLNOVO. Geographical Revenue

Figure 27 Tandem Diabetes Care, Inc.: Key Financials

Figure 28 Tandem Diabetes Care, Inc.: Segmental Revenue

Figure 29 Tandem Diabetes Care, Inc.: Geographical Revenue

Figure 30 Pancreum, Inc.: Key Financials

Figure 31 Pancreum, Inc.: Segmental Revenue

Figure 32 Pancreum, Inc.: Geographical Revenue

Figure 33 TypeZero Technologies, LLC: Key Financials

Figure 34 TypeZero Technologies, LLC: Segmental Revenue

Figure 35 TypeZero Technologies, LLC: Geographical Revenue

Figure 36 Beta Bionics: Key Financials

Figure 37 Beta Bionics: Segmental Revenue

Figure 38 Beta Bionics: Geographical Revenue

Figure 39 F. Hoffmann-La Roche Ltd: Key Financials

Figure 40 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 41 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 42 Inreda Diabetic B.V.: Key Financials

Figure 43 Inreda Diabetic B.V.: Segmental Revenue

Figure 44 Inreda Diabetic B.V.: Geographical Revenue

Figure 45 Insulet Corp: Key Financials

Figure 46 Insulet Corp: Segmental Revenue

Figure 47 Insulet Corp: Geographical Revenue